“Instead of giving patients a one-size-fits-all answer, the tool takes those findings and turns them into an individualized estimate,” said Alex Sundermann, MD, PhD.

The visit demonstrated the impact of the UCEDD model and the importance of strong, connected developmental disabilities networks.

Vanderbilt Health’s clinical care and support program for pregnant and postpartum women with substance use disorder has served 27 pregnant patients at VWCH, with the goal of serving 50-100 patients annually.

“The investment isn't only in the Wilson County of today — it’s in the physicians this community will need in 2050,” said Program Director Missy Scalise, MD.

He will help advance the society’s mission to be the global leader in sports medicine by fostering education, research, advocacy and collaboration that improve the care of athletes and active people of all ages.

The ADEPT-4 study evaluates KarXT, an oral medication that may reduce hallucinations and delusions.